Medlior Health Outcomes Research Ltd. – Trademark Portfolio
Entity Type: 03
Medlior Health Outcomes Research Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include MEDLIOR. The owner is based in Calgary, AB.
210-28 Quarry Park Blvd SE
Calgary, AB T2C5P9 , CA
Showing of trademarks Trademarks
Trademark Classifications
Medlior Health Outcomes Research Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Medlior Health Outcomes Research Ltd. have?
Medlior Health Outcomes Research Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Medlior Health Outcomes Research Ltd. file in?
Medlior Health Outcomes Research Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific). Class 35 covers advertising; business management; business administration; office functions.
What are Medlior Health Outcomes Research Ltd.'s most well-known trademarks?
Medlior Health Outcomes Research Ltd.'s registered trademark portfolio includes well-known marks such as MEDLIOR. These are among 2 currently registered trademarks in the portfolio.
What is Medlior Health Outcomes Research Ltd.'s trademark registration success rate?
Medlior Health Outcomes Research Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.